(Q33544010)

English

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Douglas T. Ross

16

object named as

Douglas T Ross

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

David G Hicks

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Bagi R Janarthanan

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Ramya Vardarajan

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Swati A Kulkarni

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Thaer Khoury

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Daniel Dim

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

G Thomas Budd

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Brian J Yoder

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Raymond Tubbs

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Marshall T Schreeder

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Noel C Estopinal

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Rodney A Beck

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Yanling Wang

13

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Brian Z Ring

14

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Robert S Seitz

15

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

22 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Identification of genes periodically expressed in the human cell cycle and their expression in tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Improved cervical smear assessment using antibodies against proteins that regulate DNA replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Interactions with single-stranded and double-stranded DNA-binding factors and alternative promoter conformation upon transcriptional activation of the Htf9-a/RanBP1 and Htf9-c genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2859753

21 June 2018

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-108

21 January 2018

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-108

21 January 2018

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-108

21 January 2018

Hormone receptor status does not affect the clinical benefit of trastuzumab therapy for patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging targeted therapies for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307320

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-108

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33544010&oldid=2195471597"